Manulife (Manufacturers Life Insurance)
ALDX icon

Manulife (Manufacturers Life Insurance)’s Aldeyra Therapeutics ALDX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.3K Sell
16,155
-866
-5% -$3.79K ﹤0.01% 2786
2025
Q4 		$88.2K Sell
17,021
-2,138
-11% -$11K ﹤0.01% 2731
2025
Q3 		$100K Sell
19,159
-915
-5% -$4.77K ﹤0.01% 2779
2025
Q2 		$76.9K Buy
20,074
+1,972
+11% +$5.1K ﹤0.01% 2816
2025
Q1 		$104K Sell
18,102
-1,059
-6% -$6.26K ﹤0.01% 2683
2024
Q4 		$95.6K Sell
19,161
-1,532
-7% -$7.86K ﹤0.01% 2825
2024
Q3 		$112K Sell
20,693
-1,041
-5% -$4.96K ﹤0.01% 2840
2024
Q2 		$71.9K Buy
21,734
+2,729
+14% +$10.7K ﹤0.01% 2908
2024
Q1 		$62.1K Hold
19,005
– – ﹤0.01% 2869
2023
Q4 		$66.7K Hold
19,005
– – ﹤0.01% 2896
2023
Q3 		$127K Hold
19,005
– – ﹤0.01% 2732
2023
Q2 		$159K Buy
+19,005
New +$187K ﹤0.01% 2687
2022
Q2 		– Sell
-22,492
Closed -$100K – 3002
2022
Q1 		$100K Sell
22,492
-5,153
-19% -$20.5K ﹤0.01% 2959
2021
Q4 		$111 Buy
27,645
+584
+2% +$4.45K ﹤0.01% 3040
2021
Q3 		$238K Sell
27,061
-1,190
-4% -$10.9K ﹤0.01% 2854
2021
Q2 		$320K Buy
+28,251
New +$340K ﹤0.01% 2768
2020
Q1 		– Sell
-15,284
Closed -$89K – 2806
2019
Q4 		$89K Sell
15,284
-1,603
-9% -$9.26K ﹤0.01% 2813
2019
Q3 		$97K Hold
16,887
– – ﹤0.01% 2827
2019
Q2 		$101K Buy
+16,887
New +$127K ﹤0.01% 2884
2018
Q3 		– Sell
-139
Closed -$1K – 2947
2018
Q2 		$1K Hold
139
– – ﹤0.01% 4235
2018
Q1 		$1K Buy
+139
New +$1.05K ﹤0.01% 4261
2017
Q4 		– Sell
-1,612
Closed -$12K – 4312
2017
Q3 		$12K Buy
1,612
+742
+85% +$3.88K ﹤0.01% 3772
2017
Q2 		$4K Sell
870
-71
-8% -$326 ﹤0.01% 3973
2017
Q1 		$5K Hold
941
– – ﹤0.01% 3772
2016
Q4 		$5K Hold
941
– – ﹤0.01% 3917
2016
Q3 		$7K Hold
941
– – ﹤0.01% 3762
2016
Q2 		$5K Hold
941
– – ﹤0.01% 3784
2016
Q1 		$4K Buy
+941
New +$4.52K ﹤0.01% 3826
2014
Q4 		– Sell
-364
Closed -$2 – 3935
2014
Q3 		$2 Buy
+364
New +$1.77K ﹤0.01% 3751

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ALDX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Aldeyra Therapeutics (ALDX) stake by 5.1% in Q1 2026, selling an estimated $3.79K and leaving 16,155 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Manulife (Manufacturers Life Insurance) first reported a position in ALDX in Q3 2014 and has held it in 29 quarters since. The position peaked at $320K in Q2 2021. 127 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 16,155 shares of Aldeyra Therapeutics worth $27.3K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 866 Aldeyra Therapeutics shares in Q1 2026, an estimated $3.79K.
  • Aldeyra Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2786 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Aldeyra Therapeutics in Q3 2014 and has held it in 29 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Aldeyra Therapeutics position peaked at $320K in Q2 2021.
  • 127 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.